Alector

A Look at 5 Big and Interesting Biotech IPOs for 2019
A Look at 5 Big and Interesting Biotech IPOs for 2019
BioSpace
IPOs
NASDAQ
Adaptive Biotechnologies
Genmab
Gossamer Bio
BridgeBio
Alector
Flag link:
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Flag link:
Alector, Prevail trade blows over alleged misuse of confidential information
Alector, Prevail trade blows over alleged misuse of confidential information
Fierce Biotech
Alector
Prevail Therapeutics
trade secrets
Flag link:
BioSpace's List of February 2019 Life Science IPOs
BioSpace's List of February 2019 Life Science IPOs
BioSpace
IPOs
Shockwave Medical
Harpoon Therapeutics
Gossamer Bio
Alector
Hoth Therapeutics
Flag link:
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials
Xconomy
Alector
IPOs
Alzheimer's disease
Flag link:
Immuno-Neurology Focused Alector Files $180 Million IPO
Immuno-Neurology Focused Alector Files $180 Million IPO
CP Wire
Alector
IPOs
immuno-neurology
Flag link:
Immuno-Neurology Focused Alector Files $180 Million IPO
Alector
Flag link:
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs
Xconomy
IPOs
Alector
Alzheimer's disease
dementia
Flag link:
Four Healthcare Startups Raised Over $130 Million Last Month
Four Healthcare Startups Raised Over $130 Million Last Month
Forbes
startups
23andMe
Gossamer Bio
Alector
Compass Therapeutics
Flag link:
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
Endpoints
AbbVie
Alzheimer's disease
Alector
R&D
Flag link:
The 2015 Fierce 15 biotech execs take a bow
The 2015 Fierce 15 biotech execs take a bow
Fierce Biotech
Alector
Arvinas
CRISPR Therapeutics
Intellia Therapeutics
NGM Biopharmaceuticals
Padlock Therapeutics
SQZ Biotech
Revolution Medicines
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
Flag link:
FierceBiotech's 2015 Fierce 15
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
Flag link:
J&J partners with a biotech start-up on a new approach to Alzheimer's
J&J partners with a biotech start-up on a new approach to Alzheimer's
Fierce Biotech
JNJ
Alzheimer's disease
Alector
Flag link: